Sale!
Replica Third-Gen EGFR-TKI Osimertinib Targeted for EGFRm NSCLC
Replica Third-Gen EGFR-TKI Osimertinib Targeted for EGFRm NSCLC - Image 2

Replica Third-Gen EGFR-TKI Osimertinib Targeted for EGFRm NSCLC

Original price was: $635.00.Current price is: $476.00.

Osimertinib, targeted therapy for EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, inhibits central nervous system metastasis, applicable for EGFR Ex19Del or EGFR L858R mutations,

SKU: SKU67EEMEWEU Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Osimertinib, targeted therapy for EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, inhibits central nervous system metastasis, applicable for EGFR Ex19Del or EGFR L858R mutations,

Related products

Scroll to Top